Artificial intelligence (AI) has emerged as a transformative force in healthcare systems and analytics, enabling the processing of vast clinical datasets to support diagnostics, prognostics, and personalized interventions. This narrative review synthesizes literature on clinical data engineering for healthcare AI, with a focused examination of labeling theory, data quality assurance, and temporal structuring standards. These elements form the foundational infrastructure for robust AI-driven healthcare systems, addressing the challenges of heterogeneous data sources, bias mitigation, and dynamic patient trajectories.Clinical data engineering encompasses the systematic preparation, integration, and optimization of healthcare data for AI models. Labeling theory, rooted in supervised learning paradigms, involves the annotation of data to train algorithms, but extends to considerations of label accuracy, inter-observer variability, and semi-supervised approaches to reduce manual effort. Data quality assurance ensures reliability through preprocessing, bias detection, and validation protocols, critical for avoiding “garbage in, garbage out” scenarios in clinical applications. Temporal structuring standards facilitate the handling of time-series data, such as electronic health records (EHRs) and longitudinal imaging, enabling predictive modeling of disease progression and real-time decision support.The review highlights AI’s role in healthcare analytics, from image-based diagnostics (e.g., dermatology and retinal disease classification) to system-level optimizations (e.g., resource allocation and workflow efficiency). It underscores the convergence of human and AI intelligence for high-performance medicine, emphasizing ethical implementations to mitigate disparities. Synthesizing cross-study insights, we propose an original framework for integrative data engineering that prioritizes interoperability, fairness, and adaptability across healthcare infrastructures.Key applications include deep learning for stroke management, cancer detection, and cardiovascular risk prediction, where data engineering directly impacts model efficacy. Challenges such as data silos, regulatory gaps, and temporal drift are addressed through original interpretive structures, including a conceptual pipeline for end-to-end AI analytics. This review positions clinical data engineering as essential for sustainable AI integration, advocating for systems-level framing that bridges data ingestion, model deployment, and governance to enhance clinical outcomes and equity in global health systems.
The integration of artificial intelligence (AI) into healthcare systems has transformed clinical analytics, particularly in improving medication safety through advanced reconciliation processes, structured error taxonomies, and careful deployment strategies. This narrative review examines how AI-driven analytics embedded within clinical infrastructures can reduce medication-related risks in hospital and ambulatory care settings. AI technologies such as natural language processing and machine learning enable automated detection of medication discrepancies by analyzing electronic health records and identifying inconsistencies that may be overlooked by manual review.AI systems also support the classification and prediction of medication errors, including prescribing mismatches and administration failures, allowing clinical decision support systems to identify high-risk prescriptions and support safer prescribing practices. In addition, AI contributes to closed-loop healthcare systems where analytics provide real-time decision support across the data lifecycle, from information ingestion to post-intervention feedback.Despite these benefits, several deployment constraints remain, including data quality limitations, interoperability challenges, and ethical concerns related to bias and governance. These factors highlight the importance of robust system design and transparent AI models to ensure safe and equitable implementation. Furthermore, AI can support standardized error taxonomies and pharmacovigilance through structured analytical frameworks that improve reporting and monitoring of adverse events.Overall, this review positions AI as a central component of adaptive clinical systems capable of strengthening medication safety. However, its effectiveness depends on addressing technical, operational, and regulatory barriers. Continued interdisciplinary collaboration will be essential to refine AI-enabled clinical analytics and support safer, more efficient healthcare systems.
Care pathways represent the temporal sequences of clinical events that define real-world patient journeys within complex healthcare systems. Recent advances in artificial intelligence have enabled the analysis of these pathways through sequence analytics, uncovering latent patterns beyond traditional guideline-based approaches. This narrative review synthesizes literature to examine three pillars of AI-enabled care pathway analytics: clustering methods that group similar patient trajectories, deviation detection techniques that identify meaningful variations from expected flows, and interpretability frameworks that support transparency and clinician trust.Drawing on process mining, sequence analysis, and explainable AI, the review highlights how electronic health record data can be transformed into actionable insights for clinical decision-making. Clustering approaches reveal hidden patient subgroups across domains such as oncology, cardiology, mental health, and critical care. Deviation detection methods expose bottlenecks, workarounds, and non-adherence associated with adverse outcomes and inefficiencies. Interpretability frameworks link algorithmic outputs to clinical logic, improving trust and adoption in healthcare settings.Cross-study evidence shows that while clustering and deviation detection methods have advanced significantly, their integration with interpretability remains limited, constraining large-scale implementation. The review proposes an integrative systems perspective that positions care pathway sequence analytics as a foundational component of AI-enabled healthcare infrastructure, encompassing data pipelines, model inference, intervention orchestration, and governance. Overall, AI-driven pathway analytics offers the potential to move healthcare from reactive, guideline-based care toward proactive, personalized, and continuously learning systems.
The integration of artificial intelligence (AI) into healthcare systems has revolutionized clinical analytics, enabling predictive modeling, diagnostic support, and personalized interventions. However, the post-deployment phase of these AI systems presents unique challenges, particularly in maintaining performance amid evolving clinical environments. This narrative review synthesizes recent literature on post-deployment monitoring strategies for clinical AI, focusing on drift detection, feedback governance, and update policies within healthcare systems and analytics frameworks. We examine how data shifts—arising from changes in patient demographics, clinical protocols, or external factors—can degrade AI model efficacy, leading to suboptimal outcomes in high-stakes settings like disease prediction and resource allocation. Drift detection emerges as a cornerstone, encompassing statistical methods to identify concept drift, covariate shift, and label drift in real-time healthcare data streams. Techniques such as nonparametric monitoring and ensemble-based approaches allow for proactive identification of performance decay, ensuring AI systems remain aligned with dynamic clinical realities. Feedback governance integrates human-in-the-loop mechanisms, where clinician inputs refine AI outputs, fostering trust and regulatory compliance in governance structures. Update policies, including retraining schedules and federated learning paradigms, to address the need for iterative model evolution without disrupting clinical workflows. We highlight systems-level perspectives, such as closed-loop architectures that link monitoring to automated updates, emphasizing interoperability across electronic health records (EHRs) and AI pipelines. Comparative analysis reveals gaps in current practices, including limited scalability in resource-constrained settings and ethical considerations in data privacy during monitoring. Through an original synthesis, we propose an integrative framework for AI lifecycle management in healthcare, underscoring the interplay between drift metrics, governance protocols, and policy-driven updates to enhance patient safety and system resilience. This review underscores the imperative for standardized monitoring protocols, informed by multidisciplinary insights, to bridge the translational gap from AI development to sustained clinical utility. By addressing these elements, healthcare AI can achieve robust, adaptive performance, ultimately improving analytics-driven decision-making and outcomes in diverse clinical contexts. Future directions include harmonizing international guidelines for AI monitoring, integrating explainable AI for better feedback loops, and leveraging emerging technologies like edge computing for real-time drift management. This synthesis provides a foundation for researchers and practitioners to advance post-deployment strategies, ensuring AI’s enduring impact on healthcare systems.
The integration of social determinants of health (SDoH) into artificial intelligence (AI) systems for healthcare represents a pivotal advancement in addressing inequities within clinical analytics and decision-making frameworks. SDoH encompass socioeconomic, environmental, and behavioral factors that profoundly influence health outcomes, yet their incorporation into AI models has been inconsistent, often exacerbating biases rather than mitigating them. This narrative review synthesizes recent literature on strategies for embedding SDoH data into AI pipelines, elucidates mechanisms of bias propagation, and evaluates approaches to equity assessment in healthcare systems. Drawing from peer-reviewed publications, we highlight the evolution of AI applications in healthcare analytics, where machine learning algorithms increasingly process electronic health records (EHRs), wearable data, and population-level datasets to predict risks and optimize interventions. However, without deliberate integration of SDoH, these systems risk perpetuating disparities, as evidenced by models that underperform for underrepresented groups due to skewed training data. Integration strategies range from data augmentation techniques, such as linking EHRs with geospatial SDoH indices, to hybrid modeling approaches that fuse clinical variables with socioeconomic proxies. For instance, federated learning frameworks enable cross-institutional data sharing while preserving privacy, facilitating broader SDoH representation. Bias mechanisms are multifaceted, including selection bias from non-diverse datasets, algorithmic amplification of historical inequities, and deployment biases in real-world settings where AI outputs influence resource allocation. Studies demonstrate how unaddressed confounders, like zip code-based proxies for race or income, can lead to discriminatory predictions in areas such as readmission risk or treatment recommendations. Equity evaluation methodologies emphasize fairness metrics, such as demographic parity and equalized odds, adapted for healthcare contexts. Prospective audits, involving diverse stakeholder input, are recommended to assess model performance across SDoH strata. Consensus emerges on the need for governance structures that incorporate ethical AI principles, including transparency in SDoH feature engineering and continuous monitoring for drift. Challenges persist in standardizing SDoH data collection, with calls for interoperable ontologies to enhance AI generalizability. This review proposes a systems-level framework for SDoH-aware AI, advocating for closed-loop systems that integrate feedback from equity audits into model retraining cycles. Ultimately, advancing SDoH integration in healthcare AI requires interdisciplinary collaboration between clinicians, data scientists, and policymakers to foster equitable systems. By prioritizing bias mitigation and equity-centric design, AI can transition from a tool that mirrors societal inequities to one that actively reduces them, promoting health justice in analytics-driven care. Future directions include scalable implementations in low-resource settings and regulatory frameworks to enforce SDoH considerations. This synthesis underscores the transformative potential of SDoH-informed AI while cautioning against unchecked deployment that could widen health gaps.
The rapid expansion of unstructured narrative data within patient safety event (PSE) reporting systems presents both a valuable source of safety intelligence and a major analytical challenge for healthcare organizations. Traditional manual review processes are labor-intensive, subjective, and incapable of scaling to the vast volumes of incident reports generated across modern health systems. Artificial intelligence techniques, particularly natural language processing and machine learning, provide scalable approaches for extracting meaningful insights from these narratives. This narrative review synthesizes advances in AI-enabled PSE analytics across three interconnected domains: automated narrative mining, data-driven taxonomy development, and integration within learning health systems that transform safety data into continuous improvement cycles. Evidence indicates that AI methods can improve event classification, accelerate detection of emerging safety signals, and reduce the analytical burden on safety teams. However, challenges remain regarding model generalisability, interpretability, and governance. AI-driven narrative analytics is emerging as a foundational component of next-generation safety intelligence infrastructures.
Clinical Intelligence Research Press